federal_register: 2016-25004

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2016-25004 Substitutability of Generic Drugs: Perceptions and Reality; Public Workshop Notice The Food and Drug Administration (FDA), in collaboration with the Johns Hopkins University Center of Excellence in Regulatory Science and Innovation, is announcing a public workshop entitled "Substitutability of Generic Drugs: Perceptions and Reality." The objective of this workshop is to discuss FDA and industry practices related to postmarket surveillance of generic drugs, postmarket generic drug research activities, public perceptions of generic drug quality and effectiveness, and verification of therapeutic equivalence of generic drugs. This workshop will also give stakeholders, including scientists from government, academia, and industry, patient advocacy groups, clinicians, pharmacists, and the general public an opportunity to provide their insights on future research needs in postmarket surveillance of generic drugs. 2016-10-17 2016 10 https://www.federalregister.gov/documents/2016/10/17/2016-25004/substitutability-of-generic-drugs-perceptions-and-reality-public-workshop https://www.govinfo.gov/content/pkg/FR-2016-10-17/pdf/2016-25004.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA), in collaboration with the Johns Hopkins University Center of Excellence in Regulatory Science and Innovation, is announcing a public workshop entitled "Substitutability of Generic Drugs: Perceptions and Reality."...  

Links from other tables